AIM Vaccine Co Ltd (6660)

Currency in HKD
4.49
-0.15(-3.23%)
Closed·

6660 Financial Summary

Key Ratios

P/E Ratio-16.19
Price/Book1.34
Debt / Equity50.99%
Return on Equity-7.43%
Dividend Yield0.00%
EBITDA-97.67M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of CNY (except for per share items)

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 11.42
(+154.45% Upside)

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
-0.12 / --
Revenue / Forecast
747.85M / --
EPS Revisions
Last 90 days

FAQ

What were AIM Vaccine's earnings for the latest quarter?

The AIM Vaccine EPS (TTM) is -0.23. AIM Vaccine reported sales of 747.85, net income of -137.98, and EPS of -0.12 for the latest quarter.

What was AIM Vaccine's net income for the latest quarter?

AIM Vaccine's net income for the latest quarter was -137.98.

How did AIM Vaccine's performance compare year-over-year in the latest quarter?

The company's revenue moved from 537.18 in the previous quarter to 747.85 in the latest quarter, and net income moved from -139.25 to -137.98 compared to the previous quarter.

What is AIM Vaccine's net profit margin on a TTM basis?

AIM Vaccine's trailing twelve months (TTM) net profit margin is -21.57%.

How does AIM Vaccine's debt to equity ratio compare to industry standards?

AIM Vaccine's total debt-to-equity ratio is 50.99%.

What is AIM Vaccine's return on investment on a TTM basis?

AIM Vaccine's trailing twelve months (TTM) return on investment (ROI) is -7.43%.

Did AIM Vaccine gain or lose cash last quarter?

In the latest quarter, AIM Vaccine's net change in cash was -31.08 million.

What were AIM Vaccine's total assets and liabilities in the latest quarter?

As of the latest quarter, AIM Vaccine reported total assets of 7,314.32 million and total liabilities of 3,090.27 million.

How has AIM Vaccine's total revenue grown this year?

AIM Vaccine's total revenue was 537.18 in the previous quarter and 747.85 in the latest quarter.

What is AIM Vaccine's gross margin on a TTM basis?

AIM Vaccine's trailing twelve months (TTM) gross margin is 74.20%.

What was AIM Vaccine's revenue per share for the latest quarter?

AIM Vaccine's revenue per share for the latest quarter was 5.50.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.